Events

Webcasts

May 13, 2008	Q1 08 Quarterly Conference Call
March 27, 2008	BioCentury Future Leaders in Biotech Conference
March 11, 2008	Q4 & FY 07 Quarterly Conference Call
February 12, 2008	10th Annual BIO CEO & Investor Conference
November 13, 2007	Q3 07 Quarterly Conference Call
September 18, 2007	ThinkEquity Partners 5th Annual Growth Conference
August 7, 2007	Q2 07 Quarterly Conference Call
May 9, 2007	Q1 07 Quarterly Conference Call
April 20, 2007	Orthostatic Hypotension Symposium
April 20, 2007	Chelsea Therapeutics Analyst Day
March 12, 2007	Q4 & FY 06 Quarterly Conference Call
May 9, 2006	Chelsea Announces Expanded Product Pipeline and Updates Clinical Developments

June 23, 2006	Dr. Ernest Choy reports data from Chelsea's Phase I trial of CH-1504 at EULAR
November 16, 2005	Dr. Oswaldo Castaneda presents results of pilot clinical trial of CH-1504 at ACR 2005

May 2006	Journal of Rheumatology publishes details of pilot clinical study; "CH-1504 appears to be clinically efficacious and may possess a superior safety and tolerance profile compared to MTX"